Title : Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's - Butler_2021_Contemp.Clin.Trials__106488 |
Author(s) : Butler T , Goldberg JD , Galvin JE , Maloney T , Ravdin L , Glodzik L , de Leon MJ , Hochman T , Bowen RL , Atwood CS |
Ref : Contemp Clin Trials , :106488 , 2021 |
Abstract : |
PubMedSearch : Butler_2021_Contemp.Clin.Trials__106488 |
PubMedID: 34166841 |
Title : A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks - Bowen_2015_J.Alzheimers.Dis_44_549 |
Author(s) : Bowen RL , Perry G , Xiong C , Smith MA , Atwood CS |
Ref : J Alzheimers Dis , 44 :549 , 2015 |
Abstract : |
PubMedSearch : Bowen_2015_J.Alzheimers.Dis_44_549 |
PubMedID: 25310993 |
Title : fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease - Trivedi_2008_Neuropsychologia_46_1667 |
Author(s) : Trivedi MA , Schmitz TW , Ries ML , Hess TM , Fitzgerald ME , Atwood CS , Rowley HA , Asthana S , Sager MA , Johnson SC |
Ref : Neuropsychologia , 46 :1667 , 2008 |
Abstract : |
PubMedSearch : Trivedi_2008_Neuropsychologia_46_1667 |
PubMedID: 18241895 |